Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Neurosalience logo — Early detection of dementia for decreasing further patient r...

Neurosalience

Early detection of dementia for decreasing further patient related costs and increasing the quality of life of patients.

Founded 2020 United Kingdom London, United Kingdom 2 employees Grant Total: $10.00K Health Care

General Information

Company Name Neurosalience
Founded Year 2020
Location United Kingdom London, United Kingdom
Employees 2
Industries Health Care
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Neurosalience. To contact Neurosalience, visit neurosalience.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Neurosalience compare?

A PDF of Neurosalience and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Neurosalience soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Neurosalience

Neurosalience, founded in 2020 and headquartered in the United Kingdom, is a health care startup with the goal of enabling the early detection of dementia through MRI scans. The company's slogan, "Early detection of dementia for decreasing further patient related costs and increasing the quality of life of patients," encapsulates their mission. Their innovative tool not only identifies dementia at an early stage but also has potential for expansion to CT scans. This technology holds the promise of reducing patient-related expenses while simultaneously enhancing the quality of life for those affected by dementia. Neurosalience's progress has garnered the attention of investors, with their most recent €10.00K grant investment coming from Prototron on 29 January 2021.

Business keywords: Medical Imaging, Dementia Detection, Diagnostic Tools, MRI Analysis, CT Scan Analysis, Healthcare Costs Reduction, Patient Quality of Life, Neurological Health, Medical Device Development

Services & Products

Early detection tool for dementia using structural MRI and CT data

Target Customers

Hospitals MedTech companies pharmaceutical companies

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant €10.00K 1
Prototron
29 Jan 2021

Neurosalience Alternatives & Competitors

View All Alternatives
Neurosalience vs
Pegwin - Patient Safety Innovation
Pegwin - Patient Safety Innovation United States

Preventive Maintenance for Humans - Early Detection of Patient Deterioration Enabling Timely Interve...

Non Equity Assistance
7 employees
Data Analytics, Enterprise Software
Neurosalience vs
HALO Precision Diagnostics
HALO Precision Diagnostics United States

Precision diagnostics for early disease detection.

Series B
180 employees
Enterprise Software, Health Care
Neurosalience vs
SpinTech MRI
SpinTech MRI United States

Developers of STAGE: 30% faster MRI scans. High-quality enhanced images. Standardized quantitative o...

Series A
19 employees
Biotechnology, Health Care
View all alternatives

FAQ About Neurosalience

Early detection of dementia for decreasing further patient related costs and increasing the quality of life of patients.
Neurosalience was founded in 2020.
Neurosalience is headquartered in London, United Kingdom.
Neurosalience operates in Health Care. Its work centres on Medical Imaging, Dementia Detection, Diagnostic Tools and MRI Analysis. Its customers include Hospitals, MedTech companies and pharmaceutical companies.
Neurosalience has approximately 2 employees.
Neurosalience has completed 1 funding round, raising a total of $10.00K. The latest funding stage is Grant.
Neurosalience offers: Early detection tool for dementia using structural MRI and CT data.
Top alternatives and competitors to Neurosalience include Pegwin - Patient Safety Innovation, HALO Precision Diagnostics, SpinTech MRI, MedQuest, AIRAmed GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Neurosalience and Pegwin - Patient Safety Innovation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Neurosalience, https://bouncewatch.com/company/neurosalience, updated 13 April 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout